天津医药 ›› 2017, Vol. 45 ›› Issue (11): 1135-1138.doi: 10.11958/20170928
• 专题-心肌梗死 • 上一篇 下一篇
赵冠棋，师树田，王晓，聂绍平
收稿日期:
修回日期:
出版日期:
发布日期:
通讯作者:
基金资助:
ZHAO Guan-qi, SHI Shu-tian, WANG Xiao, NIE Shao-ping
Received:
Revised:
Published:
Online:
赵冠棋, 师树田, 王晓, 聂绍平. STEMI合并多支血管病变的血运重建策略[J]. 天津医药, 2017, 45(11): 1135-1138.
ZHAO Guan-qi, SHI Shu-tian, WANG Xiao, NIE Shao-ping. Revascularization strategy for STEMI patients with multivessel disease[J]. Tianjin Medical Journal, 2017, 45(11): 1135-1138.
摘要： ST 段抬高型心肌梗死（STEMI）合并多支血管病变较为常见，且往往提示预后不良。在成功开通梗死相关血管后，直接 PCI （PPCI）时是否应同期处理非梗死相关血管一直存在争议。近年来，越来越多的证据提示，与仅处理梗死相关血管相比，对非梗死相关血管同期进行血运重建的患者预后较好。然而，有关非梗死相关血管的选择和处理时机仍然颇具争议。本文回顾了最新的临床证据，旨在为合并多支血管病变的 STEMI 患者的诊治提供思路。
关键词: ST段抬高型心肌梗死, 直接PCI, 多支血管病变, 非梗死相关血管, 血运重建
Abstract: ST-segment elevation myocardial infarction (STEMI) in patients with multivessel disease is a common situation, and suggests poor prognosis. After the reperfusion of infarct-related blood vessels in the primary PCI (PPCI), how to deal with the non-infarct related vessel has been a hot issue. In recent years, more and more evidence suggests that compared with treatment of infarct-related vessels only, revascularization of non-infarct related vessels will result in a better prognosis. But the timing and the choice of non-infarct-related vessel revascularization are still controversial. This article reviews the latest clinical evidence to improve the diagnosis and treatment of STEMI patients with multivessel disease.
Key words: ST-segment elevation myocardial infarction, primary PCI, multivessel disease, non-infarct related vessel, revascularization
中图分类号:
R541.4
/ 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: https://www.tjyybjb.ac.cn/CN/10.11958/20170928
https://www.tjyybjb.ac.cn/CN/Y2017/V45/I11/1135
